Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Sacituzumab govitecan
Related studies linked through entity extraction aliases.
A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED
- Status
- COMPLETED
- Phase
- PHASE2
Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
StrataPATH™ (Precision Indications for Approved Therapies)
- Status
- TERMINATED
- Phase
- PHASE2
Scalp Cooling in MBC
- Status
- RECRUITING
- Phase
- PHASE2
Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Sacituzumab Govitecan in Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2